Celgene $8 billion notes issue

3/8/2015

Acquisition finance, Investment grade bond/note issue

Value:

$ 8 billion

Status:

Completed

Date:

3/8/2015

Overview:

Biotechnology company Celgene has issued $8 billion in notes.
The offering is being used to finance Celgene's $7.2 billion acquisition of fellow US biotech company Receptos.
Bank of America Merrill Lynch, Citigroup, Deutsche Bank, and JPMorgan were the underwriters.
Davis Polk & Wardwell (Richard Truesdell) advised Celgene.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdiction:

United States

Deal types:

Acquisition finance
Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firm:

Davis Polk & Wardwell

Party: Celgene (Issuer)

Lawyer: Richard Truesdell Jr

Related deals